Autoimmunity in Down Syndrome Linked to Immune System Dysregulation
JAMA · 2023
DOI: 10.1001/jama.2023.3194 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Autoimmune Diseases, Autoimmunity, Down Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Severe Form of Mpox Identified in Patients With Advanced HIVA severe type of mpox in people with advanced HIV is characterized by necrotizing skin lesions, lung nodules, and acute infections, including sepsis, according to an analysis of 382 hospitalized patients from 19 countries published in The Lancet.This form of mpox carries a high mortality rate for those with low levels of a type of white blood cell called CD4 T lymphocytes or CD4 cells: of the 179 cases the researchers analyzed with 200 or fewer CD4 cells per mm 3 , 27 people-or 15%-died.In addition, 25% of patients with mpox who started or restarted antiretroviral therapy likely experienced an exaggerated response to the mpox infection known as immune reconstitution inflammatory syndrome.Of those 21 patients, more than half died.The researchers called for the World Health Organization and the US Centers for Disease Control and Prevention to include this form of mpox as an AIDS-defining condition to help prioritize vaccines and antivirals for those most at risk of severe disease.A linked editorial, however, cautioned that characterizing the condition as "AIDSdefining" could increase stigma around mpox and HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Harris, E. (2023). Autoimmunity in Down Syndrome Linked to Immune System Dysregulation. JAMA. https://doi.org/10.1001/jama.2023.3194
Vancouver
Harris E. Autoimmunity in Down Syndrome Linked to Immune System Dysregulation. JAMA. 2023. doi:10.1001/jama.2023.3194
BibTeX
@article{Harris2023,
author = {Harris, Emily},
title = {Autoimmunity in Down Syndrome Linked to Immune System Dysregulation},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.3194}
}
EUVIMED